what is glp 1 inhibitor The GLP-1 Agonists and Obesity: How Diabetes Drugs are Changing Non-Diabetic Lives — tl;dr pharmacy GLP-1 receptor agonists and next-generation

Effects of structured versus unstructured self-monitoring of blood glucose on glucose control in patients with non-insulin-treated type 2 diabetes: a meta-analysis of randomized controlled trials

If symptoms suggestive of thyroid dysfunction develop during semaglutide treatment, thyroid function tests should be obtained promptly rather than waiting for routine monitoring intervals

Tirzepatide targets both the GLP-1 and glucagon receptors, so its a dual agonist

The current focus extends beyond the incretin pathway to include poly-agonist therapies, activators of energy expenditure, and entirely new mechanistic classes

For adults with type 2 diabetes and established atherosclerotic cardiovascular disease, high cardiovascular risk, chronic kidney disease, or heart failure, guidelines recommend GLP-1 agonists with proven cardiovascular benefit as preferred agents, independent of metformin use or baseline A1C